Tenet Healthcare
253 hedge funds and large institutions have $3.57B invested in Tenet Healthcare in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 77 increasing their positions, 86 reducing their positions, and 32 closing their positions.
136% more call options, than puts
Call options by funds: $217M | Put options by funds: $92.1M
69% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 32
31% more capital invested
Capital invested by funds: $2.72B → $3.57B (+$854M)
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
9% more funds holding
Funds holding: 233 → 253 (+20)
6.56% less ownership
Funds ownership: 110.78% → 104.22% (-6.6%)
10% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 86
Top Buyers
Top Sellers
| 1 |
O
OrbiMed
New York
|
-$119M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$62.2M |
| 3 |
Millennium Management
New York
|
-$55.8M |
| 4 |
Goldman Sachs
New York
|
-$48.9M |
| 5 |
BCM
Brigade Capital Management
New York
|
-$15.9M |
THC Hedge Fund Activity: Q2 2018 in Review
253 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Tenet Healthcare (THC) for Q2 2018, worth a combined $3.57B — up 31% from $2.72B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new THC positions and 32 closed out — a net gain of 22 holders — while 77 added to existing stakes and 86 trimmed.
The largest buyer was Vanguard Group, adding an estimated $55.7M. The largest seller was OrbiMed, cutting an estimated $119M.
- 253 institutional investors held Tenet Healthcare (THC) as of Q2 2018, up from 233 in Q1 2018.
- Funds reported $3.57B of Tenet Healthcare stock for Q2 2018, up 31% quarter-over-quarter.
- 54 funds opened new Tenet Healthcare positions in Q2 2018 and 32 closed out, a net change of +22 holders.
- The largest Tenet Healthcare buyer in Q2 2018 was Vanguard Group, an estimated $55.7M added.
- The largest Tenet Healthcare seller in Q2 2018 was OrbiMed, an estimated $119M sold.
Based on aggregated 13F filings for Q2 2018.